Specificity of Flavor-Nutrient Learning: An fMRI Experiment

NCT ID: NCT02624206

Last Updated: 2017-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an etiology study designed to examine the how people's brains and behaviors respond to regularly consuming a beverage. Participants are assessed at 2 behavioral assessments (Wave 1 and Wave 2), 2 scans (at the BRIC), and at 9 'intervention' assessments (5-10mins) different time periods throughout the study. At their first assessment (W1) they are randomized into one of two juices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study design and Participants The investigators randomly assigned participants to consume one of two novel flavored, high-sugar beverages daily for a 3-week period. The study included fMRI and behavioral assessments pre-/post-intervention and 9 study visits during the intervention period. 20, healthy-weight, young adults (10 female, 10 male; x̅ age = 23.3±3.4; x̅ BMI = 22.1±1.9; 5% Hispanic,10% Asian/Pacific Islanders, 85% European Americans) completed protocol seen in Figure 1a. Exclusion criteria were a body mass index (BMI; kg/m2) \<18.5 or \>26.5, sweetened (artificial or caloric) beverage consumption \> 6 times/week, tobacco/e-cigarette use \> 6 times/week, psychoactive medications or drugs more than \> 1 time/month, pregnancy, head injury with a loss of consciousness, significant cognitive impairment, major medical problems, endorsement of disordered eating or current Axis I psychiatric disorder as assessed by online screener. Participants provided written informed consent; methods and procedures were approved by University of North Carolina at Chapel Hill's Institutional Review Board.

Intervention Interested participants completed a brief online screening survey those that appeared to qualify were scheduled for the baseline visit where inclusion and exclusion were confirmed and consent was reviewed and obtained. Participants were randomly assigned to one of the two juice conditions, stratified by sex. Once consented, participants completed the behavioral and perceptual measures at the baseline behavioral assessment. On a separate day participants completed the baseline neuroimaging assessment. The day following the neuroimaging assessment participants began the intervention period where they consumed their assigned juice daily for the 3-week period. During the intervention period participants came to our lab every Monday, Wednesday and Friday (9 total assessments) to: consume a portion of that day's juice in the lab, complete perceptual measures and a weight assessment, pick up the following day(s) juice, and return the empty bottles from the previous day(s). On Fridays, participants were given two bottles to consume and instructed to consume one per day and return the bottles on the following Monday. Empty bottles were returned to increase compliance. The follow-up neuroimaging assessment was scheduled such that participants completed the 3-week intervention, did not consume a juice for 24 hours and then were scanned. The follow-up behavioral assessment occurred within three days of the follow-up scan Figure 1b.

Beverages were selected to be: sweetened from sugar, i.e., not include high fructose corn syrup, and/or artificial sweeteners, have no artificial flavors, colors or preservatives, calorically equivalent to common sugar-sweetened beverages (e.g., soft drinks), be caffeine- and texture-free, and generally novel in flavor. The juices were eucaloric, had similar palatability, and easily distinguishable from one another. Prior to study initiation, pilot taste testing was completed in a small sample to insure both the novelty and equal palatability of the two juices to be included in the study. The resulting two beverages were: Apple-Cherry-Berry juice and Orange-Tangerine-Passionfruit juice. The 10 fl oz bottles of juice each contained 133 kcals, 31g of sugar. The juice logos were selected to be novel, of similar visual complexity, both in black and white, convey no information beyond a unique symbol, yet be easily distinguishable from one another. Each juice was presented in individual 10 fl oz bottles with the only identifier a sticker of the associated logo.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Feeding Behavior Inhibition (Psychology)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Juice A

Half of the group to receive Juice A, a novel juice flavor.

Group Type ACTIVE_COMPARATOR

Juice A

Intervention Type DIETARY_SUPPLEMENT

Subjects to be given juice daily for 3 weeks.

Juice B

Half of the group to receive Juice B, a novel juice flavor different from Juice A.

Group Type ACTIVE_COMPARATOR

Juice B

Intervention Type DIETARY_SUPPLEMENT

Subjects to be given juice daily for 3 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Juice A

Subjects to be given juice daily for 3 weeks.

Intervention Type DIETARY_SUPPLEMENT

Juice B

Subjects to be given juice daily for 3 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMIs between 19 and 25

Exclusion Criteria

* Contraindicators of fMRI (e.g., metal implants, braces, or pregnancy)
* Symptoms of major psychiatric disorders (substance use disorders, conduct disorder, ADHD, major depression, bipolar disorder, anorexia nervosa, bulimia nervosa, binge eating disorder)
* Active weight loss dieting
* Use of psychoactive drugs (e.g., cocaine)
* Serious medical problems (e.g., diabetes)
* Smoking
* Dietary practices that do not allow intake of dairy products during the phone screen will be excluded
Minimum Eligible Age

19 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kyle Burger, PhD, MPH, RD

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

References

Explore related publications, articles, or registry entries linked to this study.

Burger KS. Frontostriatal and behavioral adaptations to daily sugar-sweetened beverage intake: a randomized controlled trial. Am J Clin Nutr. 2017 Mar;105(3):555-563. doi: 10.3945/ajcn.116.140145. Epub 2017 Feb 8.

Reference Type DERIVED
PMID: 28179221 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P30DK056350

Identifier Type: NIH

Identifier Source: secondary_id

View Link

14-1669

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.